What Counts as a Digital Health Investor
Digital health is a wide net. It covers telehealth and virtual care, remote patient monitoring and wearables, clinical decision software, electronic health records, mental health apps, health insurance tech, and increasingly, AI tools built for clinicians and patients. If your startup uses software or data to change how care gets delivered, paid for, or managed, you are pitching a digital health investor, even if your product does not touch a hospital directly.
That breadth matters when you are choosing who to approach. A digital health angel who made their money in consumer software will look at your product differently than a venture capitalist who spent a decade funding provider-facing tools. Angel checks in the space usually run $25,000 to $500,000, the same range you would see anywhere else. Venture checks are bigger, from $2 million to $100 million or more depending on your stage, and digital health VCs tend to write on the larger end of that range once a startup has real clinical or reimbursement traction to show. Expect to give up somewhere around 15% to 25% of your company in a typical early round, whether the check comes from an angel or a fund, so factor that into how much you actually ask for.
Where Digital Health Investors Are Based
Well over half of the digital health investors in the AngelMatch database are based in the United States, with the United Kingdom, Germany, France, and India making up most of the rest. That US concentration shows up at the state and city level too. California and New York lead by a wide margin, and Massachusetts is close behind, which lines up with the Bay Area and Boston being two of the oldest health tech and biotech hubs in the country.
At the city level, San Francisco and New York City are close to each other in investor count, and both are well ahead of every other city in the database. Boston comes in third, which tracks with its hospital and university systems feeding a steady stream of clinical and life sciences founders. Outside the US, London is the single largest hub, and it is worth a look even for US-based founders once you are past your first institutional round, since UK and European digital health investors are often more comfortable with the regulatory and reimbursement questions that come with health-adjacent products.
If you are raising a first round and your company is US-based, start close to home. California, New York, and Massachusetts investors see the most digital health deal flow, which means they move faster and ask sharper questions, but it also means you are competing for attention with a lot of other founders in their inbox.
Raising Outside the US
The digital health database is not just a US list. There is a real, sizeable base of investors in the United Kingdom, Germany, and France, and a growing one in India. If your startup is based outside the US, or you are planning international expansion, these are not afterthought investors. Several of them have deep experience with the reimbursement and regulatory environments in their own markets, which can be more relevant to your specific rollout than a US fund that has never navigated a national health system.
Founders sometimes assume a European or Indian digital health investor will write a smaller check than a US fund. That is not always true, but you should expect a longer diligence process on the regulatory side, since public and private payer structures vary a lot by country and investors there tend to test whether you actually understand the market you are entering, not just the product you have built.
What Stage Digital Health Investors Fund
Seed is the single largest stage bucket among digital health investors in the database, followed by early stage venture and then a close split between Series A and pre-seed. Series B and later rounds make up a much smaller share, which is typical for a category where clinical validation and regulatory review can stretch out the path to a big growth round.
That stage distribution is a signal, not just a data point. Digital health seed rounds often take longer to close than a comparable SaaS seed round, because investors want to see some proof that your product actually works in a clinical or operational setting, not just that people click on it. Budget extra runway for that diligence period. A runway calculator can help you figure out exactly how much cushion you need if your seed round takes three or four months longer to close than you planned.
The 2025 Funding Rebound, and What It Means If You Are Raising Now
US digital health startups raised $14.2 billion across 482 deals in 2025, a 35% increase over 2024 and the highest total since 2022, according to Rock Health's year-end funding report. That is genuinely good news if you have been watching the category from the sidelines for the past two years.
But the recovery has not been evenly spread. The same report counted 26 nine-figure raises in 2025, up from 18 the year before, meaning a growing share of that $14.2 billion went into a small number of very large, very late-stage deals. If you are raising a seed or Series A round, that concentration works against you in one specific way: the headline growth number does not mean your round is easier to close, it means the biggest checks are going to fewer, more proven companies. Your job is to make it obvious, fast, why you belong in that group, not to lean on the fact that "digital health funding is up."
One bright spot worth knowing about if you are in a related category: Rock Health's report also found that fitness and wellness startups moved into the top tier of funded categories in 2025, a jump driven by wearables adoption and renewed interest in preventive care. If your product sits anywhere near that overlap, from remote monitoring to consumer-facing preventive tools, it is worth leading with that framing rather than a generic "digital health" pitch.
What Digital Health Investors Actually Want to See in a Pitch
Generic fundraising advice tells you to know your numbers and have a clear ask. That is true here too, but digital health investors are also screening for things a typical SaaS investor never asks about.
- Reimbursement path: can this get paid for by insurance, a health system, or an employer, and do you know which one?
- Clinical or operational proof: do you have pilot data, even small, that shows the product changes an outcome or a workflow?
- Regulatory status: if your product touches diagnosis or treatment, investors will ask where you stand with the FDA before they ask about your roadmap.
- Data handling: HIPAA compliance and how you handle patient data come up in nearly every serious digital health conversation, so have a real answer ready, not a slide that just says "HIPAA compliant."
Put your answers to these four questions in the first two minutes of any pitch, not buried in an appendix. Investors in this category have sat through enough pitches to know within a few minutes whether a founder actually understands the regulatory and payment landscape they are building in, and that understanding is often worth more to them than your growth chart. Have your deck built around that story before you send it, since a hosted pitch deck that tracks who opened it and how far they got can tell you fast whether investors are stalling on the reimbursement slide or the team slide.
Who Is Writing the Checks
Venture capitalists make up the largest single investor type in the digital health database, followed by private equity investors, who are more often backing later-stage, revenue-generating health tech companies than early startups. Angel and individual investors are a smaller slice by count, but they matter disproportionately at the earliest stage, since they are usually the fastest checks you can get before you have the traction a fund wants to see.
If you are pre-seed or very early seed, angels who have operated or invested in health care before are worth prioritizing over funds. They tend to move faster, ask fewer process-heavy questions, and can often make useful introductions to the clinical or regulatory contacts you will need later.
Getting Organized Before You Reach Out
Digital health rounds tend to involve more stakeholders per investor than a typical software raise, since a fund's health care partner often needs sign-off from a general partner who is not a health specialist. Track who you have talked to, what they asked, and where each conversation stalled. A fundraising CRM makes that easier to manage than a spreadsheet once you are past a dozen active conversations, especially when a single investor might loop in two or three colleagues before giving you an answer.
Digital health is one of the more resilient categories in venture right now, and the data backs that up: real capital is flowing back in, it is just going to fewer, better-prepared companies. Get your reimbursement story, your clinical proof, and your regulatory status straight before your first meeting, and pick investors whose stage and location actually match where you are today. That is a better use of your time than sending the same deck to every digital health fund you can find.
Health care investors
